Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

El efecto de la capacitación en podcast en el miedo al nacimiento en parejas: un ensayo controlado aleatorio

2 de noviembre de 2026 actualizado por: Betul Uncu, Istanbul University - Cerrahpasa

Birth fear refers to intense feelings of anxiety, fear, and worry regarding the childbirth process, often arising from concerns about physical pain, complications, or uncertainty about the baby's health. Many women experience this fear during pregnancy, which, in some cases, may develop into a clinical condition known as tokophobia . Birth fear can increase stress levels, disrupting the mother's hormonal balance, which may prolong labor, increase the risk of complications, and negatively impact fetal development. Additionally, it can lead to issues such as loss of self-confidence, anxiety, and depression in the mother, while causing communication problems and lack of support between partners. Birth fear affects not only the labor process but also the postpartum period, potentially leading to postpartum depression, trauma, and difficulties in mother-infant bonding. All these factors can adversely impact the psychosocial well-being of both women and couples. Therefore, it is crucial to develop interventions aimed at recognizing and reducing birth fear.

Descripción general del estudio

Estado

Inscripción por invitación

Intervención / Tratamiento

Descripción detallada

Podcasts, with their accessibility, low cost, and user-friendly structure, allow individuals to access health-related information more easily and personalize the educational process, making it more effective. These factors make podcasts a valuable tool, especially in areas that require emotional and cognitive intervention, such as birth fear. While birth fear is a significant psychological factor influencing the anxiety of women and their partners regarding the childbirth process, there are limited intervention-focused studies targeting couples in this area. Although various methods have been proposed in the literature to reduce birth fear, data on the effectiveness of digital educational tools like podcasts in this domain is insufficient. This research aims to fill an important gap by evaluating the effect of a podcast series on birth fear in couples. The purpose of this study is to examine how a podcast series focused on birth fear impacts birth fear, anxiety, and postpartum depression in couples.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

50

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

19 años a 35 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Descripción

Inclusion Criteria:

19-35 years old married primiparous 2nd trimester pregnant women

Exclusion Criteria:

Pregnant women with risky pregnancies illiteracy problems with internet access visual and hearing impairment

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: podcast

In accordance with the established training program for participants, a four-phase podcast listening process aimed at reducing birth fear will be implemented. The first podcast will be launched at the 33rd week of pregnancy, with the goal of helping participants gain information about the childbirth process and reduce their anxiety. Following that, a second podcast will be played at the 34th week of pregnancy, focusing on supporting psychological preparation for childbirth. The third podcast, to be implemented at the 35th week, will address topics such as relaxation techniques and breathing exercises that can be used during labor. Finally, the fourth podcast, played at the 36th week, will emphasize the importance of positive thinking and partner support during labor. To evaluate the effectiveness of the podcast sessions, psychological status and partner support scales will be applied at specific weeks.

In accordance with the established training program for participants, a four-phase podcast listening process aimed at reducing birth fear will be implemented. The first podcast will be launched at the 33rd week of pregnancy, with the goal of helping participants gain information about the childbirth process and reduce their anxiety. Following that, a second podcast will be played at the 34th week of pregnancy, focusing on supporting psychological preparation for childbirth. The third podcast, to be implemented at the 35th week, will address topics such as relaxation techniques and breathing exercises that can be used during labor. Finally, the fourth podcast, played at the 36th week, will emphasize the importance of positive thinking and partner support during labor. To evaluate the effectiveness of the podcast sessions, psychological status and partner support scales will be applied at specific weeks.

Sin intervención: control

Participants in the control group will not be provided with any podcast sessions; they will continue to benefit only from routine pregnancy follow-ups and existing healthcare services. This group will progress through the natural course without any special interventions, and standard prenatal care procedures will be applied. To measure changes in participants' birth fear and psychological conditions, data will be collected by applying specific scales at the 32nd, 37th, and 39th weeks of pregnancy. Additionally, the same scales will be used on the 2nd postpartum day to assess participants' psychological conditions after childbirth.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Wijma Delivery Expectancy Questionnaire (W-DEQ)
Periodo de tiempo: 8 month

This scale measures fear and expectations related to childbirth. Form A focuses on measuring fear of childbirth during pregnancy, while Form B assesses the postpartum process. The W-DEQ-A Form consists of 33 items. Low fear and anxiety are scored between 33-55 points, moderate fear and anxiety between 56-80 points, and high fear and anxiety between 81-165 points. It has three subscales: "Fear and Anxiety of Childbirth," "Expectations Regarding Childbirth," and "Emotional Responses to the Birth Process."

The W-DEQ-B Form consists of 14 items across three subscales: "Fear of Childbirth," "Physical Reactions," and "Psychological Reactions." Low fear is scored between 14-28 points, moderate fear between 29-49 points, and high fear between 50-70 points.

8 month

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Tilburg Pregnancy Distress Scale:
Periodo de tiempo: 8 month

This scale is used to determine the psychological stress and anxiety levels experienced during pregnancy. It measures individuals' negative feelings and thoughts regarding the pregnancy process. The scale is assessed through three subscales: "Emotional Distress," "Physical Distress," and "Social Support and Relationships." The total score reflects the intensity of the psychological and physical distress experienced by the individual during pregnancy. The total score determines the personal stress level. A score between 25-40 indicates low stress, between 41-60 indicates moderate stress, and a score of 61 and above indicates high stress.

8 month

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

14 de abril de 2026

Finalización primaria (Estimado)

7 de enero de 2027

Finalización del estudio (Estimado)

30 de enero de 2027

Fechas de registro del estudio

Enviado por primera vez

8 de abril de 2025

Primero enviado que cumplió con los criterios de control de calidad

8 de abril de 2025

Publicado por primera vez (Actual)

16 de abril de 2025

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

3 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

2 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2025/160

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

The data will not be shared due to privacy concerns and the protection of participant confidentiality. Additionally, there are no plans to make the data publicly available as the study is ongoing and the analysis is still in progress.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir